Form 4: Definitive Healthcare Corp. Executive William Moschella Reports Stock Award

William Moschella, Chief Product & Tech Officer of Definitive Healthcare Corp., reports the acquisition of 297,686 shares of Class A Common Stock through restricted stock units.

Summary

• William Moschella, Chief Product & Tech Officer at Definitive Healthcare Corp., filed a Form 4 on May 3, 2024.
• The report details the acquisition of 297,686 shares of Class A Common Stock on May 1, 2024, through the vesting of restricted stock units (RSUs).
• These RSUs consist of (i) 154,356 RSUs and (ii) 143,330 RSUs, vesting over a four-year period.
• 25% of the RSUs vest on February 1, 2025, followed by 6.25% vesting every three months thereafter over the subsequent three years, contingent upon continued service with the Issuer.
• Following the reported transaction, Moschella beneficially owns 496,912 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard executive compensation practices. The acquisition of shares by an executive is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a high-ranking officer can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs extends over a four-year period, suggesting a long-term commitment from the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This filing indicates standard equity-based compensation practices.

Comparison to Industry Standards

• Equity compensation in the form of RSUs is a common practice among publicly traded companies, particularly in the technology and healthcare sectors.
• Vesting schedules of four years with a one-year cliff (25% vesting after one year) are also typical.
• Comparable companies like Veeva Systems and Cerner (now Oracle Health) also utilize RSUs as part of their executive compensation packages.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation.
• The vesting of RSUs incentivizes the executive to remain with the company and contribute to its long-term success.

Key Dates